Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
6,081 studies for “Pfizer”
- TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast CancerActive Not Recruiting
Sponsor: Georgetown University
Breast Cancer
United States
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Australia, France, Germany, Israel +4 more
Sponsor: Pfizer
Breast Cancer
Japan, South Korea, Taiwan
- Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell CarcinomaNot Yet Recruiting
Sponsor: Shanghai Zhongshan Hospital
Oral Squamous Cell Carcinoma (OSCC) · Oropharyngeal Squamous Cell Carcinoma (OPSCC)
China
Sponsor: Pfizer
Alopecia Areata
United States, Canada, Japan
- A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia
United States, Japan, Netherlands
Sponsor: Pfizer
Atopic Dermatitis
United States
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom
- Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesActive Not Recruiting
Sponsor: Pfizer
Breast Cancer · Head and Neck Cancer
United States, China, Mexico, South Korea, Taiwan +2 more
Sponsor: Pfizer
Overweight · Obesity · Healthy
Belgium
Sponsor: Pfizer
Healthy Adults
China
- A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast CancerActive Not Recruiting
Sponsor: Pfizer
Breast Cancer · Breast Neoplasms
United States, Australia, Brazil, Canada, Germany +4 more
- A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossNot Yet Recruiting
Sponsor: Pfizer
Non-small Cell Lung Cancer (NSCLC) · Cachexia
- A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised AdultsRecruiting
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
United States
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active Not Recruiting
Sponsor: Pfizer
Obesity · Overweight and/or Obesity · Overweight · Diabetes, Type 2
United States, Argentina, Bulgaria, Canada, Czechia +6 more
- Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibActive Not Recruiting
Sponsor: Pfizer
Alopecia Areata
United States, China, France, Italy, Japan +1 more
Sponsor: Eli Lilly and Company
Breast Neoplasms · Neoplasm Metastasis
United States, Argentina, Australia, Belgium, Brazil +14 more
- A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in KoreaRecruiting
Sponsor: Pfizer
Complicated Intra-abdominal Infection · Complicated Urinary Tract Infection · Hospital-acquired Pneumonia
South Korea
Sponsor: Pfizer
Pneumococcal Disease
United States, Japan, Puerto Rico
Sponsor: Duke University
HER2+ Metastatic Breast Cancer (MBC)
United States
Sponsor: Pfizer
Healthy
United States
Sponsor: Pfizer
Non-muscle Invasive Bladder Cancer
United States, France, Israel, South Korea, Spain +1 more
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive Not Recruiting
Sponsor: Pfizer
mCRPC
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityNot Yet Recruiting
Sponsor: Pfizer
Obesity · Overweight
China
6,081 studies found